Jang G, Park R, Esteva E, Hsu P, Feng J, Upadhaya S
J Exp Med. 2025; 222(6).
PMID: 40072317
PMC: 11899982.
DOI: 10.1084/jem.20240587.
Rueckels M, Picard-Mareau M
F1000Res. 2025; 11():1405.
PMID: 39834660
PMC: 11745302.
DOI: 10.12688/f1000research.123975.1.
Lill C, Fitter S, Zannettino A, Vandyke K, Noll J
Cancer Metastasis Rev. 2024; 43(4):1385-1399.
PMID: 39102101
PMC: 11554931.
DOI: 10.1007/s10555-024-10203-9.
Wang H, Chen R, Yang W, Li Y, Muthukumar R, Patel R
Cell Rep. 2024; 43(8):114542.
PMID: 39046877
PMC: 11423277.
DOI: 10.1016/j.celrep.2024.114542.
Jiang C, Gonzalez-Anton S, Li X, Mi E, Wu L, Zhao H
F1000Res. 2024; 11:1491.
PMID: 38798305
PMC: 11128051.
DOI: 10.12688/f1000research.125877.2.
The insertion/deletion polymorphism rs201494641 at influences blood CD34 cell levels by altering ZNF384 binding.
Cafaro C, Ali Z, Lamarca A, Di Bello D, Lozano L, Ekdahl L
Haematologica. 2024; 109(9):3059-3062.
PMID: 38721738
PMC: 11367236.
DOI: 10.3324/haematol.2024.285363.
Made to order: emergency myelopoiesis and demand-adapted innate immune cell production.
Swann J, Olson O, Passegue E
Nat Rev Immunol. 2024; 24(8):596-613.
PMID: 38467802
DOI: 10.1038/s41577-024-00998-7.
α1,3-fucosylation treatment improves cord blood CD34 negative hematopoietic stem cell navigation.
Al-Amoodi A, Kai J, Li Y, Malki J, Alghamdi A, Al-Ghuneim A
iScience. 2024; 27(2):108882.
PMID: 38322982
PMC: 10845921.
DOI: 10.1016/j.isci.2024.108882.
Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).
Zhao L, Leung L, Morser J
Methods Mol Biol. 2023; 2747:95-117.
PMID: 38038935
DOI: 10.1007/978-1-0716-3589-6_9.
Thrombin Cleavage of Osteopontin and the Host Anti-Tumor Immune Response.
Leung L, Myles T, Morser J
Cancers (Basel). 2023; 15(13).
PMID: 37444590
PMC: 10340489.
DOI: 10.3390/cancers15133480.
Osteopontin as a Biomarker in Chronic Kidney Disease.
Sinha S, Mellody M, Carpio M, Damoiseaux R, Nicholas S
Biomedicines. 2023; 11(5).
PMID: 37239027
PMC: 10216241.
DOI: 10.3390/biomedicines11051356.
High ploidy large cytoplasmic megakaryocytes are hematopoietic stem cells regulators and essential for platelet production.
Heazlewood S, Ahmad T, Cao B, Cao H, Domingues M, Sun X
Nat Commun. 2023; 14(1):2099.
PMID: 37055407
PMC: 10102126.
DOI: 10.1038/s41467-023-37780-7.
Functions and regulatory mechanisms of resting hematopoietic stem cells: a promising targeted therapeutic strategy.
Tang X, Wang Z, Wang J, Cui S, Xu R, Wang Y
Stem Cell Res Ther. 2023; 14(1):73.
PMID: 37038215
PMC: 10088186.
DOI: 10.1186/s13287-023-03316-5.
The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies.
Zhang H, Liesveld J, Calvi L, Lipe B, Xing L, Becker M
Bone Res. 2023; 11(1):15.
PMID: 36918531
PMC: 10014945.
DOI: 10.1038/s41413-023-00249-w.
Osteopontin (OPN)/SPP1: from its biochemistry to biological functions in the innate immune system and the central nervous system (CNS).
Lin E, Xi W, Aggarwal N, Shinohara M
Int Immunol. 2022; 35(4):171-180.
PMID: 36525591
PMC: 10071791.
DOI: 10.1093/intimm/dxac060.
Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche.
Fallati A, Di Marzo N, DAmico G, Dander E
Cancers (Basel). 2022; 14(14).
PMID: 35884364
PMC: 9323332.
DOI: 10.3390/cancers14143303.
An integrin axis induces IFN-β production in plasmacytoid dendritic cells.
Simoes D, Paschalidis N, Kourepini E, Panoutsakopoulou V
J Cell Biol. 2022; 221(9).
PMID: 35878016
PMC: 9354318.
DOI: 10.1083/jcb.202102055.
Peptide Mediated Adhesion to Beta-Lactam Ring of Equine Mesenchymal Stem Cells: A Pilot Study.
Merlo B, Baldassarro V, Flagelli A, Marcoccia R, Giraldi V, Focarete M
Animals (Basel). 2022; 12(6).
PMID: 35327131
PMC: 8944785.
DOI: 10.3390/ani12060734.
Insights Into Bone Marrow Niche Stability: An Adhesion and Metabolism Route.
Ashok D, Polcik L, Dannewitz Prosseda S, Hartmann T
Front Cell Dev Biol. 2022; 9:798604.
PMID: 35118078
PMC: 8806031.
DOI: 10.3389/fcell.2021.798604.
Thrombin cleavage of osteopontin initiates osteopontin's tumor-promoting activity.
Peraramelli S, Zhou Q, Zhou Q, Wanko B, Zhao L, Nishimura T
J Thromb Haemost. 2022; 20(5):1256-1270.
PMID: 35108449
PMC: 9289821.
DOI: 10.1111/jth.15663.